Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

16.60
+0.73004.60%
Post-market: 16.900.3000+1.81%19:41 EDT
Volume:2.41M
Turnover:39.30M
Market Cap:1.97B
PE:-14.34
High:16.85
Open:16.03
Low:15.70
Close:15.87
Loading ...

Arcutis Biotherapeutics: Resilient Performance and Growth Potential Amidst Short-Term Fluctuations

TIPRANKS
·
25 Nov 2024

Arcutis Biotherapeutics, Inc. (ARQT) Crossed Above the 50-Day Moving Average: What That Means for Investors

Zacks
·
20 Nov 2024

Bears are Losing Control Over Arcutis Biotherapeutics (ARQT), Here's Why It's a 'Buy' Now

Zacks
·
19 Nov 2024

Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average

Zacks
·
19 Nov 2024

TD Cowen Sticks to Their Buy Rating for Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
11 Nov 2024

Stock Track | Arcutis Biotherapeutics Jumps 5% as Q3 Earnings Top Estimates

Stock Track
·
08 Nov 2024

Arcutis Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
08 Nov 2024

Stock Track | Arcutis Biotherapeutics Soars Over 6% on Robust Q3 Results and Strong Growth Outlook

Stock Track
·
07 Nov 2024

Stock Track | Arcutis Biotherapeutics Soars Over 5% Premarket on Strong Q3 Results

Stock Track
·
07 Nov 2024

Arcutis Biotherapeutics: Strong Q3 Performance and Strategic Growth Drive Buy Rating

TIPRANKS
·
07 Nov 2024

Arcutis Biotherapeutics Price Target Maintained With a $18.00/Share by Needham

Dow Jones
·
07 Nov 2024

Arcutis Biotherapeutics Inc (ARQT) Q3 2024 Earnings Call Highlights: Robust Growth and ...

GuruFocus.com
·
07 Nov 2024

Arcutis Biotherapeutics Reports Strong Q3 2024 Results

TIPRANKS
·
07 Nov 2024

Arcutis Biotherapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
07 Nov 2024

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
07 Nov 2024

Arcutis Biotherapeutics Q3 2024 GAAP EPS $(0.33) Beats $(0.43) Estimate, Sales $44.755M Beat $37.617M Estimate

Benzinga
·
07 Nov 2024